News Releases Home Synthetic Biology The History of Synthetic Biology Living Medicines Designing Synthetic Biotic™ Medicines Pipeline + Programs For Patients Our People Leadership Board of Directors Founders and Advisors Join Us Investors + Media Company Overview News & Events News Releases Event Calendar Presentations & Publications Stock Information Corporate Governance Financials Investor Resources Items Per Page 102550 Year None201920182017201620152014 June 12, 2019 Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic™ Medicines May 22, 2019 Synlogic Announces Clinical Collaboration to Evaluate SYNB1891 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors May 9, 2019 Synlogic Reports First Quarter 2019 Financial Results and Provides Business Update May 2, 2019 Synlogic Announces First Quarter 2019 Conference Call and Webcast April 30, 2019 Synlogic Presents Data Describing a Solid Oral Formulation Process for Synthetic Biotic™ Medicine SYNB1618 for the Treatment of PKU at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) April 15, 2019 Synlogic to Present Data from New Solid Oral Formulation Process at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) April 9, 2019 Synlogic Appoints Scott Plevy M.D. as Chief Scientific Officer April 2, 2019 Synlogic to Webcast Presentation at the 18th Annual Needham Healthcare Conference March 13, 2019 Synlogic to Webcast Presentation at the Oppenheimer 29th Annual Healthcare Conference March 12, 2019 Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page next › Last page last » Displaying 1 - 10 of 84 Email Alerts Contact IR RSS Feeds Print Page Email Page
Items Per Page 102550 Year None201920182017201620152014 June 12, 2019 Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic™ Medicines May 22, 2019 Synlogic Announces Clinical Collaboration to Evaluate SYNB1891 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors May 9, 2019 Synlogic Reports First Quarter 2019 Financial Results and Provides Business Update May 2, 2019 Synlogic Announces First Quarter 2019 Conference Call and Webcast April 30, 2019 Synlogic Presents Data Describing a Solid Oral Formulation Process for Synthetic Biotic™ Medicine SYNB1618 for the Treatment of PKU at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) April 15, 2019 Synlogic to Present Data from New Solid Oral Formulation Process at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) April 9, 2019 Synlogic Appoints Scott Plevy M.D. as Chief Scientific Officer April 2, 2019 Synlogic to Webcast Presentation at the 18th Annual Needham Healthcare Conference March 13, 2019 Synlogic to Webcast Presentation at the Oppenheimer 29th Annual Healthcare Conference March 12, 2019 Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page next › Last page last » Displaying 1 - 10 of 84
June 12, 2019 Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic™ Medicines
May 22, 2019 Synlogic Announces Clinical Collaboration to Evaluate SYNB1891 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors
April 30, 2019 Synlogic Presents Data Describing a Solid Oral Formulation Process for Synthetic Biotic™ Medicine SYNB1618 for the Treatment of PKU at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
April 15, 2019 Synlogic to Present Data from New Solid Oral Formulation Process at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
March 12, 2019 Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update